Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospectively Randomized Study on Neoadjuvant Radio-Chemotherapy in Patients With Operated Rectal Carcinoma Dukes B and C (pT2, pN1-3; pT3-4, pN0-3; M0.

NCT00309517 is registered in ClinicalTrials.gov with Austrian Breast & Colorectal Cancer Study Group as lead sponsor.

NCT NCT00309517
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00309517 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospectively Randomized Study on Neoadjuvant Radio-Chemotherapy in Patients With Operated Rectal Carcinoma Dukes B and C (pT2, pN1-3; pT3-4, pN0-3; M0.
Lead sponsor
Austrian Breast & Colorectal Cancer Study Group
Phase
Phase 3
Overall status
Terminated
Start date
July 31, 1997
Completion date
Not reported
Enrollment
700
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

rectal cancer dukes b, dukes c